ESC Premium Access

Identification of atrial fibrillation patients who are at high bleeding risk after undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI trial

Congress Presentation

About the speaker

Doctor Tarek Nafee

Harvard Medical School, Boston (United States of America)
0 follower

6 more presentations in this session

NOACs versus warfarin in atrial fibrillation patients and risk of dementia: a nationwide propensity-weighted cohort study

Speaker: Mrs M. Soegaard (Aalborg, DK)


Resuming anticoagulation in patients with atrial fibrillation experiencing hemorrhage stroke or nontraumatic intracranial hemorrhage

Speaker: Assistant Professor V. Wu (Tao-Yuan, TW)


Geographic region, stroke risk and renal function strongly affect treatment choice for stroke prevention in patients with non-valvular AF: results from the GLORIA-AF registry program

Speaker: Doctor L. Riou Franca (Ingelheim, DE)


Thrombosis of left atrial appendage closure devices - What is the clinical impact?

Speaker: Doctor V. Lekesova (Prague, CZ)


Effect of anticoagulation on mortality by CHADSVASC score in patients with atrial fibrillation: comparison to patients without atrial fibrillation

Speaker: Doctor S. Harb (Cleveland, US)


Access the full session

Atrial fibrillation - Anticoagulation

Speakers: Doctor T. Nafee, Mrs M. Soegaard, Assistant Professor V. Wu, Doctor L. Riou Franca, Doctor V. Lekesova...

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by